Cancer stem cells and human malignant melanoma

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• Cancer stem cells (CSCs) are implicated in tumor initiation, progression, and treatment resistance across various cancers.
• Malignant melanoma is an aggressive cancer known for its drug resistance and propensity for recurrence.
• Evidence suggests melanoma heterogeneity and plasticity point to the existence of malignant melanoma stem cells (MMSCs).

Purpose of the Study:

• To review the evidence for MMSC involvement in melanoma initiation, propagation, and therapy resistance.
• To connect MMSC characteristics with known melanoma pathobiology, including signaling pathways and genomic instability.
• To propose MMSC-targeted therapies for improved melanoma treatment outcomes.

Main Methods:

• Review of existing literature on cancer stem cells and melanoma biology.
• Analysis of melanoma subpopulations exhibiting stem-like properties.
• Discussion of deregulated signaling pathways, genomic instability, and vasculogenic mimicry in melanoma.

Main Results:

• MMSCs share functional similarities with CSCs in other cancers and with normal melanocyte stem cells.
• MMSC characteristics align with observed melanoma heterogeneity, undifferentiated signatures, and tumorigenicity.
• Deregulated pathways, genomic instability, and vasculogenic mimicry in melanoma subpopulations support the MMSC concept.

Conclusions:

• A subset of MMSCs likely drives melanoma's therapy resistance, invasiveness, and progression.
• Targeting the MMSC compartment offers a potential strategy for achieving stable remissions in metastatic melanoma.
• Further research into MMSC biology is crucial for developing effective melanoma treatments.